Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pain in patients with multiple sclerosis: a population-based study.

Kristina Bacher Svendsen1, Troels Staehelin Jensen, Kim Overvad

  • 1Danish Pain Research Center, Building 1A, Aarhus University Hospital, Noerrebrogade 44, DK-8000 Aarhus C, Denmark. kristina@akhphd.au.dk.

Archives of Neurology
|August 20, 2003
PubMed
Summary

Pain is common in multiple sclerosis (MS) patients, but not more frequent than in the general population. However, MS-related pain is more intense and impacts daily life significantly.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the association between familial hemiplegic migraine genes (<i>CACNA1A</i>, <i>ATP1A2</i> and <i>SCN1A</i>) with migraine and epilepsy: A UK Biobank exome-wide association study.

Cephalalgia : an international journal of headache·2025
Same author

Impact of variability in baseline pain on the placebo response in randomized, placebo-controlled, crossover trials in peripheral neuropathic pain.

Pain·2021
Same author

Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 3rd edition, 2020.

The journal of headache and pain·2021
Same author

Assessment of Pain Modulatory and Somatosensory Profiles in Chronic Tension-Type Headache Patients.

Pain medicine (Malden, Mass.)·2021
Same author

A randomized, controlled trial of a β2-agonist in painful polyneuropathy.

Pain·2020
Same author

Factors with impact on magnitude of the placebo response in randomized, controlled, cross-over trials in peripheral neuropathic pain.

Pain·2020

Area of Science:

  • Neurology
  • Pain Medicine
  • Epidemiology

Background:

  • Pain is a significant symptom for multiple sclerosis (MS) patients, with prevalence estimates ranging widely from 30% to 90%.
  • Previous research has often lacked comprehensive population samples of MS patients.
  • Understanding pain in MS is crucial for patient care and management.

Purpose of the Study:

  • To determine the prevalence of pain in a population-based sample of individuals with multiple sclerosis (MS).
  • To characterize the clinical features of pain experienced by MS patients.
  • To assess the impact of pain on the daily lives of MS patients compared to a reference group.

Main Methods:

  • A postal survey was conducted in Aarhus County, Denmark.
  • The study included 771 patients with definite MS and 769 individuals from a sex- and age-stratified general population reference group.

Related Experiment Videos

  • Data collected included pain prevalence, intensity, treatment requirements, and interference with daily life.
  • Main Results:

    • Response rates were 81.3% for MS patients and 63.3% for the reference group.
    • Pain prevalence in the preceding month was 79.4% for MS patients and 74.7% for the reference group.
    • MS patients reported significantly higher pain intensity, greater daily analgesic use (24.4% vs 9.0%), and more frequent interference of pain with daily life.

    Conclusions:

    • The overall frequency of reported pain did not differ significantly between MS patients and the general population.
    • However, MS patients experienced more severe pain, required more analgesic treatment, and reported a greater negative impact of pain on their daily functioning.
    • These findings highlight the substantial burden of pain in multiple sclerosis, even if its prevalence is similar to the general population.